Question 12643 — pharmacy and medications

Summary

Ms. Sandrine Lalanne draws the attention of the Minister of Health, Families, Autonomy and People with Disabilities to the situation of patients who have developed meningiomas following prolonged consumption of synthetic progestins such as Androcur, Lutéran or Lutényl, prescribed as part of medical treatments. From the beginning of the 2000s, warning signals about the dangerousness of these specialties pharmaceuticals were already available. However, it is only since 2018 that the National Medicines Safety Agency (ANSM) has taken measures to alert health professionals and patients of the consequences incurred. Several scientific studies now establish a causal link between prolonged exposure to these drugs and the development of non-cancerous brain tumors (meningiomas), sometimes multiple. and leading to serious after-effects. To date, more than 750 files have been compiled or are in the process of being compiled, 70 legal or amicable proceedings have been initiated and around forty definitive expert reports confirm this causal link. The AMAVEA association has repeatedly called on the Ministry of Health to propose the establishment of an amicable compensation system, similar to what was done for the Pick or Dépakine. Accompanied by a panel of experts specializing in synthetic progestins, this system would make it possible to harmonize procedures, avoid particularly grueling medical assessments for victims and ensure faster and more equitable compensation. Also, it asks him to specify the measures that the Government intends to take with a view to establishing such an amicable compensation system and, more broadly, the actions planned to help people affected by the serious side effects of these treatments.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.